Literature DB >> 29470785

The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?

Zuzana Hlavata1, Cinzia Solinas2, Pushpamali De Silva3, Michele Porcu4, Luca Saba4, Karen Willard-Gallo3, Mario Scartozzi5.   

Abstract

Radiotherapy is one of the main treatment strategies used in cancer. Aside from the local control of the disease, which is mediated by a direct cytotoxic effect on tumor cells, radiotherapy has also been shown to exert immune-mediated local and systemic effects. Radiotherapy can elicit anti-tumor responses in distant sites from the radiation field; this phenomenon is known as the abscopal effect and has been described in patients previously treated with immune checkpoint blockade (ICB). Considering that the efficacy of immunotherapy has been demonstrated only in a subset of patients-who often benefit with lasting responses-efforts are ongoing to potentiate its activity with the development of new combination strategies. Radiotherapy might represent a potential candidate for a synergistic combination with immunotherapy, by improving the immunogenicity of tumors and by enhancing local and systemic immune effects. This review aims to summarize the current pre-clinical and clinical data on the immune effects of radiotherapy and their potential implications for cancer immunotherapy.

Entities:  

Mesh:

Year:  2018        PMID: 29470785     DOI: 10.1007/s11523-018-0556-3

Source DB:  PubMed          Journal:  Target Oncol        ISSN: 1776-2596            Impact factor:   4.493


  46 in total

1.  Subversion of anticancer immunosurveillance by radiotherapy.

Authors:  Laurence Zitvogel; Guido Kroemer
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 2.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 3.  Radiotherapy and immunogenic cell death.

Authors:  Encouse B Golden; Lionel Apetoh
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 4.  Radiation as an immune modulator.

Authors:  Byron Burnette; Ralph R Weichselbaum
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

5.  TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.

Authors:  Claire Vanpouille-Box; Julie M Diamond; Karsten A Pilones; Jiri Zavadil; James S Babb; Silvia C Formenti; Mary Helen Barcellos-Hoff; Sandra Demaria
Journal:  Cancer Res       Date:  2015-04-09       Impact factor: 12.701

Review 6.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

7.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

8.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

Review 9.  The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?

Authors:  Zishuo I Hu; Heather L McArthur; Alice Y Ho
Journal:  Curr Breast Cancer Rep       Date:  2017-03-02

Review 10.  Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.

Authors:  Anja Derer; Lisa Deloch; Yvonne Rubner; Rainer Fietkau; Benjamin Frey; Udo S Gaipl
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

View more
  9 in total

Review 1.  Antitumour dendritic cell vaccination in a priming and boosting approach.

Authors:  Alexandre Harari; Michele Graciotti; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  Nat Rev Drug Discov       Date:  2020-08-06       Impact factor: 84.694

Review 2.  Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field.

Authors:  Carrie Anne Minnaar; Andras Szasz
Journal:  Cells       Date:  2022-06-04       Impact factor: 7.666

Review 3.  Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review.

Authors:  Michele Porcu; Cinzia Solinas; Cristina Migali; Angelo Battaglia; Marina Schena; Lorenzo Mannelli; Alfredo Addeo; Karen Willard-Gallo; Luca Saba
Journal:  Target Oncol       Date:  2020-02       Impact factor: 4.864

Review 4.  Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?

Authors:  Cinzia Solinas; Marco Aiello; Esdy Rozali; Matteo Lambertini; Karen Willard-Gallo; Edoardo Migliori
Journal:  Transl Oncol       Date:  2020-07-01       Impact factor: 4.243

5.  Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses.

Authors:  Xiaodong Jiang; Viswanathan Muthusamy; Olga Fedorova; Yong Kong; Daniel J Kim; Marcus Bosenberg; Anna Marie Pyle; Akiko Iwasaki
Journal:  J Exp Med       Date:  2019-10-10       Impact factor: 14.307

6.  Local Irradiation Sensitized Tumors to Adoptive T Cell Therapy via Enhancing the Cross-Priming, Homing, and Cytotoxicity of Antigen-Specific CD8 T Cells.

Authors:  Jin-Zhi Lai; Yan-Yang Zhu; Mei Ruan; Ling Chen; Qiu-Yu Zhang
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

7.  Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients.

Authors:  Carrie Anne Minnaar; Jeffrey Allan Kotzen; Olusegun Akinwale Ayeni; Mboyo-Di-Tamba Vangu; Ans Baeyens
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

Review 8.  The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy.

Authors:  Cinzia Solinas; Chunyan Gu-Trantien; Karen Willard-Gallo
Journal:  ESMO Open       Date:  2020-01

Review 9.  Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.

Authors:  Antonino Musolino; Cinzia Solinas; Benedetta Pellegrino; Zuzana Hlavata; Cristina Migali; Pushpamali De Silva; Marco Aiello; Karen Willard-Gallo
Journal:  Mol Diagn Ther       Date:  2021-05-11       Impact factor: 4.074

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.